Drug Pipeline

GnP Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Phase 3
3
Top Sponsors
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-11 NCT06835569
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With…		 Enrollment increased: 188 -> 448 participants
2026-06-11 NCT06835569
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With…		 Trial arms changed: 2 -> 10
2026-06-09 NCT07562152
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic…		 Trial sites expanded: 10 -> 13 locations
2026-06-05 NCT07562152
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic…		 Trial sites expanded: 6 -> 10 locations
Active Studies by Phase
Phase 3
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07562152 Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic… Pancreatic Cancer Recruiting
NCT07336953 A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus… PDAC - Pancreatic Ductal Adenocarcinoma Not Yet Recruiting
Phase 1
NCT06835569 A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With… Cancer Recruiting
Sponsors Running GnP Trials
Alterome Therapeutics, Inc. (1) West China Hospital (1) Immuneering Corporation (1)
Disease Areas
Pancreatic Cancer (3) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Colorectal Cancer (1)
Get alerts when GnP trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free